Novel N-hydroxamic acid hydrazide inhibitors of TNF-α synthesis

被引：0
|
作者：
机构：
来源：
EXPERT OPINION ON THERAPEUTIC PATENTS | 2000年 / 10卷 / 10期
关键词：
ADAM-17; rheumatoid arthritis; TACE; TNF-alpha; TNF synthesis inhibitor;
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Two patent applications claim novel N-hydroxamic acid hydrazide inhibitors of TNF-alpha synthesis, that act via inhibition of the TNF-alpha-converting enzyme (TACE or ADAM-17). The hydrazides are claimed to be useful in the treatment of inflammatory diseases such as rheumatoid arthritis. The claimed sulphonylhydrazide and cyclic hydrazide derivatives both display comparable in vitro potency to Roche's clinical development lead Ro 32-7315.
引用
收藏
页码：1617 / 1621
页数：5
相关论文
共 50 条
  • [1] Novel cyclic N-hydroxamic acid inhibitors of TNF-α synthesis and MMP-13
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (12) : 1951 - 1956
  • [2] N-hydroxamic inhibitors of CD23
    不详
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2002, 12 (01) : 135 - 137
  • [3] Solid-phase synthesis of hydroxamic acid based TNF-α convertase inhibitors
    Barlaam, B
    Koza, P
    Berriot, J
    TETRAHEDRON, 1999, 55 (23) : 7221 - 7232
  • [4] Design, synthesis and evaluation of β-benzamido hydroxamic acid inhibitors of TNF-α converting enzyme (TACE).
    Ott, GR
    Lu, ZH
    Asakawa, N
    Covington, MB
    Qian, MX
    Liu, RQ
    Newton, RC
    Christ, DD
    Decicco, CP
    Duan, JJW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U966 - U966
  • [5] Identification of N-hydroxamic acid and N-hydroxyimide compounds that inhibit the influenza virus polymerase
    Cianci, C
    Chung, TDY
    Meanwell, N
    Putz, H
    Hagen, M
    Colonno, RJ
    Krystal, M
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1996, 7 (06): : 353 - 360
  • [6] α,β-cyclic-β-benzamido hydroxamic acids:: Novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-α converting enzyme (TACE)
    Ott, Gregory R.
    Asakawa, Naoyuki
    Lu, Zhonghui
    Liu, Rui-Qin
    Covington, Maryanne B.
    Vaddi, Krishna
    Qian, Mingxin
    Newton, Robert C.
    Christ, David D.
    Traskos, James M.
    James, Carl P. Decicco
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (02) : 694 - 699
  • [7] Design and synthesis of novel pyrimidine hydroxamic acid inhibitors of histone deacetylases
    Donald, Alastair D. G.
    Clark, Vanessa L.
    Patel, Sanjay
    Day, Francesca A.
    Rowlands, Martin G.
    Wibata, Judata
    Stimson, Lindsay
    Hardcastle, Anthea
    Eccles, Sue A.
    McNamara, Deborah
    Needham, Lindsey A.
    Raynaud, Florence I.
    Aherne, Wynne
    Moffat, David F.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (22) : 6657 - 6660
  • [8] Benzobicyclooctanes as novel inhibitors of TNF-α signaling
    Jackson, RW
    Gelinas, R
    Baughman, TA
    Cox, T
    Howbert, JJ
    Kucera, KA
    Latham, JA
    Ramsdell, F
    Singh, D
    Darwish, IS
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (07) : 1093 - 1097
  • [9] Novel chromene derivatives as TNF-α inhibitors
    Cheng, JF
    Ishikawa, A
    Ono, Y
    Arrhenius, T
    Nadzan, A
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (21) : 3647 - 3650
  • [10] Novel diarylheptanoids as inhibitors of TNF-α production
    Dhuru, Sameer
    Bhedi, Dilip
    Gophane, Dnyaneshwar
    Hirbhagat, Kiran
    Nadar, Vijaya
    More, Dattatray
    Parikh, Sapna
    Dalal, Roda
    Fonseca, Lyle C.
    Kharas, Firuza
    Vadnal, Prashant Y.
    Vishwakarma, Ram A.
    Sivaramakrishnan, H.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (12) : 3784 - 3787
12345